Effect of preinjury statin use on mortality and septic shock in elderly burn patients

Journal of Trauma - Injury, Infection and Critical Care

Volumn 69, Issue 1, 2010, Pages 99-103

  Fogerty, Mary D ^a   Efron, David ^c   Morandi, Alessandro ^d   Guy, Jeffrey S ^a   Abumrad, Naji N ^a   Barbul, Adrian ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

Burn; Elderly; Sepsis; Statin

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; BURN PATIENT; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DEATH; DEMOGRAPHY; DIABETES MELLITUS; DRUG EFFECT; DRUG USE; FEMALE; HEALTH CARE FACILITY; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; HYPERTENSION; INCIDENCE; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT INFORMATION; PERIPHERAL VASCULAR DISEASE; PREMEDICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK; SEPSIS; SEPTIC SHOCK; THERMAL INJURY;

AGED; BURNS; CONFIDENCE INTERVALS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SHOCK, SEPTIC;

EID: 77954701429     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e3181df61b1     Document Type: Article

References (18)

1. Bloemsma GC, Dokter J, Boxma H, Oen IM. Mortality and causes of death in a burn centre. Burns. 2008;34:1103-1107.
2. Woodward B, Cartwright M. Safety of drotrecogin alfa (activated) in severe sepsis: data from adult clinical trials and observational studies. J Crit Care. 2009;24:595-602.
3. Efron DT, Sorock G, Haut ER, et al. Preinjury statin use is associated with improved in-hospital survival in elderly trauma patients. J Trauma. 2008;64:66-74.
4. Almog Y, Shefer A, Novack V, et al. Prior statin therapy is associated with a decreased rate of severe sepsis. Circulation. 2004;110:880-885.
5. Chua D, Tsang RS, Kuo IF. The role of statin therapy in sepsis. Ann Pharmacother. 2007;41:647-652.
6. Merx MW, Weber C. Statins in the intensive care unit. Curr Opin Crit Care. 2006;12:309-314.
7. Levy MM, Fink MP, Marshall JC, et al; SCCM/ESICM/ACCP/ATS/ SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31:1250-1256.
8. American Burn Association. National Burn Repository® 2009.Version 5.0. Chicago, IL: ABP; 2009.
9. Falagas ME, Makris GC, Matthaiou DK, Rafailidis PI. Statins for infection and sepsis: a systematic review of the clinical evidence. J Antimicrob Chemother. 2008;61:774-785.
10. Heeschen C, Hamm CW, Laufs U, Snapinn S, Böhm M, White HD; Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators. Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation. 2002;105:1446-1452.
11. Larose E, Ganz P. Statins and endothelial dysfunction. Semin Vasc Med. 2004;4:333-346.
12. Chaudhry MZ, Wang JH, Blankson S, Redmond HP. Statin (cerivastatin) protects mice against sepsis-related death via reduced proinflammatory cytokines and enhanced bacterial clearance. Surg Infect (Larchmt). 2008;9:183-194.
13. Lennernas H, Fager G. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences. Clin Pharmacokinet. 1997;32:403-425.
14. Scalia R, Stalker TJ. Microcirculation as a target for the antiinflammatory properties of statins. Microcirculation. 2002;9:431-442.
15. Istvan ES, Deisenhofer J. Structural mechanism for statin inhibition of HMG-CoA reductase. Science. 2001;292:1160-1164.
16. McGown CC, Brookes ZL. Beneficial effects of statins on the microcirculation during sepsis: the role of nitric oxide. Br J Anaesth. 2007; 98:163-175.
17. Kashani A, Phillips CO, Foody JM, et al. Risks associated with statin therapy: a systematic overview of randomized clinical trials. Circulation. 2006;114:2788-2797.
18. Armitage J. The safety of statins in clinical practice. Lancet. 2007;370: 1781-1790.